Serum Irisin Level In Leprosy Patients.

This article discusses a clinical trial, NCT06416033, that is investigating the levels of a protein called irisin in leprosy patients. The trial aims to measure the plasma irisin levels in leprosy patients and compare them to healthy controls. It also aims to examine the correlation of irisin levels in different types of leprosy. Leprosy is a chronic infectious disease that primarily affects peripheral nerves, mucosa, bones, and other organs. The trial will provide valuable insights into the role of irisin in leprosy and its potential implications for the disease. The study is being conducted in Egypt and is expected to be completed by July 15, 2024. [Extracted from the article]